Notice Title

Consent to the Distribution of a New Medicine

Publication Date
13 Apr 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go1450
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: TAKHZYRO
Active Ingredient: Lanadelumab 150mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Takeda New Zealand Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Catalent Indiana LLC, Indiana, United States of America


Dated this 6th day of April 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).